(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CLIEXA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CLIEXA

ST13

US500000098783056

Class

42

Filing

98783056

Registration

7964625

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

05/10/2026

Trademark type

Combined

Nice classes

42

Filing date

10/02/2024

Registration date

09/30/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/30/2025

Last transaction

05/10/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

05/18/2016

First use in commerce

05/18/2016

Drawing code

3

Owner type

03

Owner location

Denver, CO, US

Examiner

CLARK, ROBERT C

Law office

L10

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the literal element "CLIEXA" written in a stylized form wherein the letter "C" is depicted as a magnifying glass focusing on a randomly shaped virus.

Holders and representatives

Holders

Collaborative Network 4 Clinical Excellence, Inc.

Representatives

Michael Markos LEGALFORCE RAPC WORLDWIDE, P.C.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Providing on-line non-downloadable software as a service (SaaS) using artificial intelligence (AI) for analyzingsynthesizingintegrating medical data to generate clinical insights and decision support; Providing on-line non downloadable software as a service (SaaS) using artificial intelligence (AI) for medical data managementintegrationanalysis; Providing temporary use of a web-based nondownloadable white label computer platform for businesses to provide customizedAI-driven medical data solutions to end usersincluding the ability for users to download associated applications in a business to business consumer model.

Publications

History of USPTO decisions and trademark events.

24 publications found

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

05/08/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/08/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/08/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/08/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/30/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

09/30/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/12/2025

PUBO

PUBLISHED FOR OPPOSITION

08/12/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/06/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/02/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

07/01/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/01/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/01/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/01/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/02/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/02/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/02/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/09/2025

GNRT

NON-FINAL ACTION E-MAILED

04/09/2025

CNRT

NON-FINAL ACTION WRITTEN

04/09/2025

DOCK

ASSIGNED TO EXAMINER

04/09/2025

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

04/08/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/08/2025

NWAP

NEW APPLICATION ENTERED

10/02/2024

Continuous trademark protection

Get notified about every new filing that threatens CLIEXA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.